Infectious Disease Point Of Care Testing - Current And Future Players

Infectious Disease Point of Care Testing - Current and Future Players Summary The infectious disease point of care testing (POCT) market is very fragmented, with over 100 players currently marketing products in their portfolio; thus

Region : 03165902 | Price: 2900 | Report ID: 03165902
Infectious Disease Point of Care Testing - Current and Future Players


The infectious disease point of care testing (POCT) market is very fragmented, with over 100 players currently marketing products in their portfolio; thus, competition and pricing pressures in the development and marketing of infectious disease POCT devices are intense. There are a large number of multinational and regional competitors making investments in competing technologies and products. The competitive factors in the POC space include fast turnaround time of test results, price, reimbursement, data handling techniques, and analytical performance, as well as the R&D, marketing, promotion, and brand name recognition of the company.

The report provides up-to-date information and in-depth analysis on the key players that shape the global infectious disease POCT market. The report also includes analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources and primary research interviews with key opinion leaders.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.


- Investigation of current and future market competition in the infectious disease POCT market.
- Competitive Assessment including product profiles.
- Pipeline Assessment including 62 pipeline products.
- Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the infectious disease POCT market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Key Players in the Infectious Disease POCT Market
3 Introduction
3.1 Catalyst
3.2 Related Reports
4 Industry Overview
4.1 Infectious Disease POCT Overview
4.2 Mergers, Acquisitions, and Key Partnerships
5 Competitive Assessment
5.1 Company Share Analysis
5.1.1 Global
5.2 Alere
5.2.1 Overview
5.2.2 Marketed Products Assessment
5.2.3 SWOT Analysis
5.3 Beckman Coulter
5.3.1 Overview
5.3.2 Marketed Products Assessment
5.3.3 SWOT Analysis
5.4 BioMerieux
5.4.1 Overview
5.4.2 Marketed Products Assessment
5.4.3 SWOT Analysis
5.5 Cepheid
5.5.1 Overview
5.5.2 Marketed Products Assessment
5.5.3 SWOT Analysis
5.6 Chembio Diagnostics
5.6.1 Overview
5.6.2 Marketed Products Assessment
5.6.3 SWOT Analysis
5.7 Meridian Bioscience
5.7.1 Overview
5.7.2 Marketed Products Assessment
5.7.3 SWOT Analysis
5.8 OraSure Technologies
5.8.1 Overview
5.8.2 Marketed Products Assessment
5.8.3 SWOT Analysis
5.9 Quidel
5.9.1 Overview
5.9.2 Marketed Products Assessment
5.9.3 SWOT Analysis
5.10 Roche Diagnostics
5.10.1 Overview
5.10.2 Marketed Products Assessment
5.10.3 SWOT Analysis
5.11 Trinity Biotech
5.11.1 Overview
5.11.2 Marketed Products Assessment
5.11.3 SWOT Analysis
5.12 Other Companies
5.12.1 North American Market Companies
5.12.2 European Market Companies
5.12.3 APAC and Other Markets Companies
6 Pipeline Assessment
6.1 Overview
6.2 Early Development Pipelines
6.3 Pre-Clinical Stage Pipelines
6.4 Clinical Stage Pipelines
6.5 Pipelines in Approval Process
7 Appendix
7.1 Bibliography
7.2 Abbreviations
7.3 Report Methodology
7.3.1 Overview
7.3.2 Coverage
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research - Key Opinion Leader Interviews
7.3.6 Primary Research - Physician and Industry Interviews
7.3.7 Expert Panel Validation
7.4 About the Team
7.4.1 Analysts
7.4.2 Tyler Fletcher, Global Head of Medical Devices
7.5 About MediPoint
7.6 About GlobalData
7.7 Contact Us
7.8 Disclaimer


Research Methodology


Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

The market engineered data is verified and validated by a number of experts, both in-house and external.

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.